Antisense Oligonucleotide-Based Therapies for Diseases Caused by pre-mRNA Processing Defects (original) (raw)

• Aartsma-Rus A (2012) Overview on AON design. Methods Mol Biol 867:117–129
  CAS PubMed Google Scholar
• Allerson CR, Sioufi N, Jarres R, Prakash TP, Naik N, Berdeja A, Wanders L, Griffey RH, Swayze EE, Bhat B (2005) Fully 2′-modified oligonucleotide duplexes with improved in vitro potency and stability compared to unmodified small interfering RNA. J Med Chem 48:901–904
  CAS PubMed Google Scholar
• Allo M, Buggiano V, Fededa JP, Petrillo E, Schor I, de la Mata M, Agirre E, Plass M, Eyras E, Elela SA et al (2009) Control of alternative splicing through siRNA-mediated transcriptional gene silencing. Nat Struct Mol Biol 16:717–724
  CAS PubMed Google Scholar
• Anthony K, Gallo JM (2010) Aberrant RNA processing events in neurological disorders. Brain Res 1338:67–77
  CAS PubMed Google Scholar
• Araujo Ade Q, Araujo M, Swoboda KJ (2009) Vascular perfusion abnormalities in infants with spinal muscular atrophy. J Pediatr 155:292–294
  Google Scholar
• Arora V, Knapp DC, Smith BL, Statdfield ML, Stein DA, Reddy MT, Weller DD, Iversen PL (2000) c-Myc antisense limits rat liver regeneration and indicates role for c-Myc in regulating cytochrome P-450 3A activity. J Pharmacol Exp Ther 292:921–928
  CAS PubMed Google Scholar
• Bachelin M, Hessler G, Kurz G, Hacia JG, Dervan PB, Kessler H (1998) Structure of a stereoregular phosphorothioate DNA/RNA duplex. Nat Struct Biol 5:271–276
  CAS PubMed Google Scholar
• Baker BF, Lot SS, Condon TP, Cheng-Flournoy S, Lesnik EA, Sasmor HM, Bennett CF (1997) 2′-O-(2-Methoxy)ethyl-modified anti-intercellular adhesion molecule 1 (ICAM-1) oligonucleotides selectively increase the ICAM-1 mRNA level and inhibit formation of the ICAM-1 translation initiation complex in human umbilical vein endothelial cells. J Biol Chem 272:11994–12000
  CAS PubMed Google Scholar
• Baker BF, Lot SS, Kringel J, Cheng-Flournoy S, Villiet P, Sasmor HM, Siwkowski AM, Chappell LL, Morrow JR (1999) Oligonucleotide-europium complex conjugate designed to cleave the 5′ cap structure of the ICAM-1 transcript potentiates antisense activity in cells. Nucleic Acids Res 27:1547–1551
  CAS PubMed Central PubMed Google Scholar
• Baker BF, Miraglia L, Hagedorn CH (1992) Modulation of eucaryotic initiation factor-4E binding to 5′-capped oligoribonucleotides by modified anti-sense oligonucleotides. J Biol Chem 267:11495–11499
  CAS PubMed Google Scholar
• Baltz AG, Munschauer M, Schwanhausser B, Vasile A, Murakawa Y, Schueler M, Youngs N, Penfold-Brown D, Drew K, Milek M et al (2012) The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts. Mol Cell 46:674–690
  CAS PubMed Google Scholar
• Barresi R, Campbell KP (2006) Dystroglycan: from biosynthesis to pathogenesis of human disease. J Cell Sci 119:199–207
  CAS PubMed Google Scholar
• Bartel DP (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116: 281–297
  CAS PubMed Google Scholar
• Bartel DP (2009) MicroRNAs: target recognition and regulatory functions. Cell 136:215–233
  CAS PubMed Central PubMed Google Scholar
• Batey RT, Rambo RP, Doudna JA (1999) Tertiary Motifs in RNA Structure and Folding. Angewandte Chemie 38:2326–2343
  PubMed Google Scholar
• Baughan TD, Dickson A, Osman EY, Lorson CL (2009) Delivery of bifunctional RNAs that target an intronic repressor and increase SMN levels in an animal model of spinal muscular atrophy. Hum Mol Genet 18(9):1600–1611
  CAS PubMed Central PubMed Google Scholar
• Bauman J, Jearawiriyapaisarn N, Kole R (2009) Therapeutic potential of splice-switching oligonucleotides. Oligonucleotides 19(1):1–13
  CAS PubMed Central PubMed Google Scholar
• Baumer D, Lee S, Nicholson G, Davies JL, Parkinson NJ, Murray LM, Gillingwater TH, Ansorge O, Davies KE, Talbot K (2009) Alternative splicing events are a late feature of pathology in a mouse model of spinal muscular atrophy. PLoS Genet 5:e1000773
  PubMed Central PubMed Google Scholar
• Belostotsky D (2009) Exosome complex and pervasive transcription in eukaryotic genomes. Curr Opin Cell Biol 21:352–358
  CAS PubMed Google Scholar
• Bennett CF (2007) Pharmacological properties of 2′-O-methoxyethyl-modified oligonucleotides. In: Crooke ST (ed) Antisense drug technology: principles, strategies, and applications. CRC, Boca Raton, FL, pp 273–303
  Google Scholar
• Bennett CF, Chiang MY, Chan H, Grimm S (1993) Use of cationic lipids to enhance the biological activity of antisense oligonucleotides. J Liposome Res 3:85–102
  CAS Google Scholar
• Bennett CF, Swayze EE (2010) RNA targeting therapeutics: molecular mechanisms of antisense oligonucleotides as a therapeutic platform. Annu Rev Pharmacol Toxicol 50:259–293
  CAS PubMed Google Scholar
• Bevan AK, Hutchinson KR, Foust KD, Braun L, McGovern VL, Schmelzer L, Ward JG, Petruska JC, Lucchesi PA, Burghes AH et al (2010) Early heart failure in the SMNDelta7 model of spinal muscular atrophy and correction by postnatal scAAV9-SMN delivery. Hum Mol Genet 19:3895–3905
  CAS PubMed Central PubMed Google Scholar
• Bitner-Glindzicz M, Lindley KJ, Rutland P, Blaydon D, Smith VV, Milla PJ, Hussain K, Furth-Lavi J, Cosgrove KE, Shepherd RM et al (2000) A recessive contiguous gene deletion causing infantile hyperinsulinism, enteropathy and deafness identifies the Usher type 1C gene. Nat Genet 26:56–60
  CAS PubMed Google Scholar
• Black DL (2003) Mechanisms of alternative pre-messenger RNA splicing. Annu Rev Biochem 72:291–336
  CAS PubMed Google Scholar
• Braasch DA, Paroo Z, Constantinescu A, Ren G, Oz OK, Mason RP, Corey DR (2004) Biodistribution of phosphodiester and phosphorothioate siRNA. Bioorg Med Chem Lett 14:1139–1143
  CAS PubMed Google Scholar
• Brachet J (1941) La détection histochimique et le microdosage des acides pentosenucléiques (tissus animaux—développement embryonnaire des amphibiens). Enzymologia 10:87–96
  CAS Google Scholar
• Braunschweig U, Gueroussov S, Plocik AM, Graveley BR, Blencowe BJ (2013) Dynamic integration of splicing within gene regulatory pathways. Cell 152:1252–1269
  CAS PubMed Central PubMed Google Scholar
• Breaker RR, Joyce GF (1994) A DNA enzyme that cleaves RNA. Chem Biol 1:223–229
  CAS PubMed Google Scholar
• Brook JD, McCurrach ME, Harley HG, Buckler AJ, Church D, Aburatani H, Hunter K, Stanton VP, Thirion JP, Hudson T et al (1992) Molecular basis of myotonic dystrophy: expansion of a trinucleotide (CTG) repeat at the 3′ end of a transcript encoding a protein kinase family member. Cell 68:799–808
  CAS PubMed Google Scholar
• Brown-Driver V, Eto T, Lesnik E, Anderson KP, Hanecak RC (1999) Inhibition of translation of hepatitis C virus RNA by 2-modified antisense oligonucleotides. Antisense Nucleic Acid Drug Dev 9:145–154
  CAS PubMed Google Scholar
• Bumcrot D, Manoharan M, Koteliansky V, Sah DW (2006) RNAi therapeutics: a potential new class of pharmaceutical drugs. Nat Chem Biol 2:711–719
  CAS PubMed Google Scholar
• Burel SA, Han SR, Lee HS, Norris DA, Lee BS, Machemer T, Park SY, Zhou T, He G, Kim Y et al (2013) Preclinical evaluation of the toxicological effects of a novel constrained ethyl modified antisense compound targeting signal transducer and activator of transcription 3 in mice and cynomolgus monkeys. Nucleic Acid Ther 23:213–227
  CAS PubMed Google Scholar
• Burel SA, Machemer T, Ragone FL, Kato H, Cauntay P, Greenlee S, Salim A, Gaarde WA, Hung G, Peralta R et al (2012) Unique O-methoxyethyl ribose-DNA chimeric oligonucleotide induces an atypical melanoma differentiation-associated gene 5-dependent induction of type I interferon response. J Pharmacol Exp Ther 342:150–162
  CAS PubMed Google Scholar
• Burghes AH, Beattie CE (2009) Spinal muscular atrophy: why do low levels of survival motor neuron protein make motor neurons sick? Nat Rev Neurosci 10:597–609
  CAS PubMed Central PubMed Google Scholar
• Butler M, Hayes CS, Chappell A, Murray SF, Yaksh TL, Hua XY (2005) Spinal distribution and metabolism of 2′-O-(2-methoxyethyl)-modified oligonucleotides after intrathecal administration in rats. Neuroscience 131:705–715
  CAS PubMed Google Scholar
• Calandra S, Tarugi P, Bertolini S (2011) Altered mRNA splicing in lipoprotein disorders. Curr Opin Lipidol 22:93–99
  CAS PubMed Google Scholar
• Calarco JA, Zhen M, Blencowe BJ (2011) Networking in a global world: Establishing functional connections between neural splicing regulators and their target transcripts. RNA 17(5): 775–791
  CAS PubMed Central PubMed Google Scholar
• Carroll JB, Warby SC, Southwell AL, Doty CN, Greenlee S, Skotte N, Hung G, Bennett CF, Freier SM, Hayden MR (2011) Potent and selective antisense oligonucleotides targeting single-nucleotide polymorphisms in the Huntington disease gene/allele-specific silencing of mutant huntingtin. Mol Ther: J Am Soc Gene Therapy 19:2178–2185
  CAS Google Scholar
• Cartegni L, Krainer AR (2003) Correction of disease-associated exon skipping by synthetic exon-specific activators. Nat Struct Biol 10:120–125
  CAS PubMed Google Scholar
• Carthew RW, Sontheimer EJ (2009) Origins and mechanisms of miRNAs and siRNAs. Cell 136:642–655
  CAS PubMed Central PubMed Google Scholar
• Castanotto D, Rossi JJ (2009) The promises and pitfalls of RNA-interference-based therapeutics. Nature 457:426–433
  CAS PubMed Central PubMed Google Scholar
• Castello A, Fischer B, Eichelbaum K, Horos R, Beckmann BM, Strein C, Davey NE, Humphreys DT, Preiss T, Steinmetz LM et al (2012) Insights into RNA biology from an atlas of mammalian mRNA-binding proteins. Cell 149:1393–1406
  CAS PubMed Google Scholar
• Castello A, Fischer B, Hentze MW, Preiss T (2013) z. Trends Genet 29:318–327
  CAS PubMed Google Scholar
• Cech TR (1988) Ribozymes and their medical implications. JAMA 260:3030–3034
  CAS PubMed Google Scholar
• Cerritelli SM, Crouch RJ (2009) Ribonuclease H: the enzymes in eukaryotes. FEBS J 276: 1494–1505
  CAS PubMed Central PubMed Google Scholar
• Chastain M, Tinoco I Jr (1993) RNA structure as related to antisense drugs. In: Lebleu STCAB (ed) Antisense research and applications. CRC, Boca Raton, FL, pp 55–66
  Google Scholar
• Chirboga C, Swoboda K, Darras B, Iannaccone S, Montes J, Allen H, Parad R, Johnson S, De Vivo D, Norris D et al (2013) Results of an open-label, escalating dose study to assess the safety, tolerability, and dose range finding of a single intrathecal dose of ISIS-SMNRx in patients with spinal muscular atrophy. In 65th American Academy of Neurology Annual Meeting, abstract S36002
  Google Scholar
• Cho S, Dreyfuss G (2010) A degron created by SMN2 exon 7 skipping is a principal contributor to spinal muscular atrophy severity. Genes Dev 24:438–442
  CAS PubMed Central PubMed Google Scholar
• Choi WY, Giraldez AJ, Schier AF (2007) Target protectors reveal dampening and balancing of Nodal agonist and antagonist by miR-430. Science 318:271–274
  CAS PubMed Google Scholar
• Chu Y, Yue X, Younger ST, Janowski BA, Corey DR (2010) Involvement of argonaute proteins in gene silencing and activation by RNAs complementary to a non-coding transcript at the progesterone receptor promoter. Nucleic Acids Res 38:7736–7748
  CAS PubMed Central PubMed Google Scholar
• Cifuentes-Diaz C, Frugier T, Tiziano FD, Lacene E, Roblot N, Joshi V, Moreau MH, Melki J (2001) Deletion of murine SMN exon 7 directed to skeletal muscle leads to severe muscular dystrophy. J Cell Biol 152:1107–1114
  CAS PubMed Central PubMed Google Scholar
• Cirak S, Arechavala-Gomeza V, Guglieri M, Feng L, Torelli S, Anthony K, Abbs S, Garralda ME, Bourke J, Wells DJ et al (2011) Exon skipping and dystrophin restoration in patients with Duchenne muscular dystrophy after systemic phosphorodiamidate morpholino oligomer treatment: an open-label, phase 2, dose-escalation study. Lancet 378:595–605
  CAS PubMed Central PubMed Google Scholar
• Coady TH, Lorson CL (2010) Trans-splicing-mediated improvement in a severe mouse model of spinal muscular atrophy. J Neurosci 30:126–130
  CAS PubMed Central PubMed Google Scholar
• Cooper TA, Wan L, Dreyfuss G (2009) RNA and disease. Cell 136:777–793
  CAS PubMed Central PubMed Google Scholar
• Coovert DD, Le TT, McAndrew PE, Strasswimmer J, Crawford TO, Mendell JR, Coulson SE, Androphy EJ, Prior TW, Burghes AH (1997) The survival motor neuron protein in spinal muscular atrophy. Hum Mol Genet 6:1205–1214
  CAS PubMed Google Scholar
• Crawford TO, Pardo CA (1996) The neurobiology of childhood spinal muscular atrophy. Neurobiol Dis 3:97–110
  CAS PubMed Google Scholar
• Crooke ST, Graham MJ, Zuckerman JE, Brooks D, Conklin BS, Cummins LL, Greig MJ, Guinosso CJ, Kornbrust D, Manoharan M et al (1996) Pharmacokinetic properties of several novel oligonucleotide analogs in mice. J Pharmacol Exp Ther 277:923–937
  CAS PubMed Google Scholar
• Crooke ST, Vickers T, Lima W, Wu H (2007) Mechanisms of antisense drug action, an introduction. In: Crooke ST (ed) Antisense drug technology: principles, strategies, and applications. CRC, Boca Raton, FL, pp 3–46
  Google Scholar
• Danckwardt S, Hentze MW, Kulozik AE (2008) 3′ end mRNA processing: molecular mechanisms and implications for health and disease. EMBO J 27:482–498
  CAS PubMed Central PubMed Google Scholar
• Davis BM, McCurrach ME, Taneja KL, Singer RH, Housman DE (1997) Expansion of a CUG trinucleotide repeat in the 3′ untranslated region of myotonic dystrophy protein kinase transcripts results in nuclear retention of transcripts. Proc Natl Acad Sci U S A 94:7388–7393
  CAS PubMed Central PubMed Google Scholar
• Davis S, Propp S, Freier SM, Jones LE, Serra MJ, Kinberger G, Bhat B, Swayze EE, Bennett CF, Esau C (2009) Potent inhibition of microRNA in vivo without degradation. Nucleic Acids Res 37:70–77
  CAS PubMed Central PubMed Google Scholar
• De Sandre-Giovannoli A, Bernard R, Cau P, Navarro C, Amiel J, Boccaccio I, Lyonnet S, Stewart CL, Munnich A, Le Merrer M et al (2003) Lamin a truncation in Hutchinson-Gilford progeria. Science 300:2055
  PubMed Google Scholar
• Dechat T, Pfleghaar K, Sengupta K, Shimi T, Shumaker DK, Solimando L, Goldman RD (2008) Nuclear lamins: major factors in the structural organization and function of the nucleus and chromatin. Genes Dev 22:832–853
  CAS PubMed Central PubMed Google Scholar
• DeJesus-Hernandez M, Mackenzie IR, Boeve BF, Boxer AL, Baker M, Rutherford NJ, Nicholson AM, Finch NA, Flynn H, Adamson J et al (2011) Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron 72:245–256
  CAS PubMed Central PubMed Google Scholar
• Devos SL, Miller TM (2013) Direct intraventricular delivery of drugs to the rodent central nervous system. J Vis Exp 75:e50326
  PubMed Google Scholar
• Dickson A, Osman E, Lorson CL (2008) A negatively acting bifunctional RNA increases survival motor neuron both in vitro and in vivo. Hum Gene Ther 19:1307–1315
  CAS PubMed Central PubMed Google Scholar
• Djebali S, Davis CA, Merkel A, Dobin A, Lassmann T, Mortazavi A, Tanzer A, Lagarde J, Lin W, Schlesinger F et al (2012) Landscape of transcription in human cells. Nature 489:101–108
  CAS PubMed Central PubMed Google Scholar
• Doench JG, Petersen CP, Sharp PA (2003) siRNAs can function as miRNAs. Genes Dev 17:438–442
  CAS PubMed Central PubMed Google Scholar
• Dominguez E, Marais T, Chatauret N, Benkhelifa-Ziyyat S, Duque S, Ravassard P, Carcenac R, Astord S, de Moura AP, Voit T et al (2011) Intravenous scAAV9 delivery of a codon-optimized SMN1 sequence rescues SMA mice. Hum Mol Genet 20:681–693
  CAS PubMed Google Scholar
• Dominski Z, Kole R (1993) Restoration of correct splicing in thalassemic pre-mRNA by antisense oligonucleotides. Proc Natl Acad Sci U S A 90:8673–8677
  CAS PubMed Central PubMed Google Scholar
• Du H, Cline MS, Osborne RJ, Tuttle DL, Clark TA, Donohue JP, Hall MP, Shiue L, Swanson MS, Thornton CA et al (2010) Aberrant alternative splicing and extracellular matrix gene expression in mouse models of myotonic dystrophy. Nat Struct Mol Biol 17:187–193
  CAS PubMed Central PubMed Google Scholar
• Dunckley MG, Manoharan M, Villiet P, Eperon IC, Dickson G (1998) Modification of splicing in the dystrophin gene in cultured Mdx muscle cells by antisense oligoribonucleotides. Hum Mol Genet 7:1083–1090
  CAS PubMed Google Scholar
• Echeverria GV, Cooper TA (2012) RNA-binding proteins in microsatellite expansion disorders: mediators of RNA toxicity. Brain Res 1462:100–111
  CAS PubMed Central PubMed Google Scholar
• Ecker DJ (1993) Strategies for invasion of RNA secondary structure. In: Lebleu STCAB (ed) Antisense research and applications. CRC, Boca Raton, FL, pp 387–400
  Google Scholar
• Eckstein F (2000) Phosphorothioate oligodeoxynucleotides: what is their origin and what is unique about them? Antisense Nucleic Acid Drug Dev 10:117–121
  CAS PubMed Google Scholar
• Egli M, Pallan PS, Allerson CR, Prakash TP, Berdeja A, Yu J, Lee S, Watt A, Gaus H, Bhat B et al (2011) Synthesis, improved antisense activity and structural rationale for the divergent RNA affinities of 3′-fluoro hexitol nucleic acid (FHNA and Ara-FHNA) modified oligonucleotides. J Am Chem Soc 133:16642–16649
  CAS PubMed Central PubMed Google Scholar
• El-Matary W, Kotagiri S, Cameron D, Peart I (2004) Spinal muscle atrophy type 1 (Werdnig-Hoffman disease) with complex cardiac malformation. Eur J Pediatr 163:331–332
  PubMed Google Scholar
• Elbashir SM, Harborth J, Lendeckel W, Yalcin A, Weber K, Tuschl T (2001) Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 411:494–498
  CAS PubMed Google Scholar
• Elmen J, Lindow M, Schutz S, Lawrence M, Petri A, Obad S, Lindholm M, Hedtjarn M, Hansen HF, Berger U et al (2008) LNA-mediated microRNA silencing in non-human primates. Nature 452:896–899
  CAS PubMed Google Scholar
• Eriksson M, Brown WT, Gordon LB, Glynn MW, Singer J, Scott L, Erdos MR, Robbins CM, Moses TY, Berglund P et al (2003) Recurrent de novo point mutations in lamin A cause Hutchinson-Gilford progeria syndrome. Nature 423:293–298
  CAS PubMed Google Scholar
• Esau C, Davis S, Murray SF, Yu XX, Pandey SK, Pear M, Watts L, Booten SL, Graham M, McKay R et al (2006) miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting. Cell Metab 3:87–98
  CAS PubMed Google Scholar
• Esau C, Kang X, Peralta E, Hanson E, Marcusson EG, Ravichandran LV, Sun Y, Koo S, Perera RJ, Jain R et al (2004) MicroRNA-143 regulates adipocyte differentiation. J Biol Chem 279:52361–52365
  CAS PubMed Google Scholar
• Faghihi MA, Kocerha J, Modarresi F, Engstrom PG, Chalk AM, Brothers SP, Koesema E, St Laurent G, Wahlestedt C (2010) RNAi screen indicates widespread biological function for human natural antisense transcripts. PLoS One 5
  Google Scholar
• Faghihi MA, Wahlestedt C (2009) Regulatory roles of natural antisense transcripts. Nat Rev Mol Cell Biol 10:637–643
  CAS PubMed Central PubMed Google Scholar
• Fallini C, Bassell GJ, Rossoll W (2012) Spinal muscular atrophy: the role of SMN in axonal mRNA regulation. Brain Res 1462:81–92
  CAS PubMed Central PubMed Google Scholar
• Fardaei M, Larkin K, Brook JD, Hamshere MG (2001) In vivo co-localisation of MBNL protein with DMPK expanded-repeat transcripts. Nucleic Acids Res 29:2766–2771
  CAS PubMed Central PubMed Google Scholar
• Feldkotter M, Schwarzer V, Wirth R, Wienker TF, Wirth B (2002) Quantitative analyses of SMN1 and SMN2 based on real-time light Cycler PCR: fast and highly reliable carrier testing and prediction of severity of spinal muscular atrophy. Am J Hum Genet 70:358–368
  CAS PubMed Central PubMed Google Scholar
• Fiszer A, Mykowska A, Krzyzosiak WJ (2011) Inhibition of mutant huntingtin expression by RNA duplex targeting expanded CAG repeats. Nucleic Acids Res 39:5578–5585
  CAS PubMed Central PubMed Google Scholar
• Fong LG, Ng JK, Lammerding J, Vickers TA, Meta M, Cote N, Gavino B, Qiao X, Chang SY, Young SR et al (2006) Prelamin A and lamin A appear to be dispensable in the nuclear lamina. J Clin Invest 116:743–752
  CAS PubMed Central PubMed Google Scholar
• Foust KD, Wang X, McGovern VL, Braun L, Bevan AK, Haidet AM, Le TT, Morales PR, Rich MM, Burghes AH et al (2010) Rescue of the spinal muscular atrophy phenotype in a mouse model by early postnatal delivery of SMN. Nat Biotechnol 28:271–274
  CAS PubMed Central PubMed Google Scholar
• Francois V, Klein AF, Beley C, Jollet A, Lemercier C, Garcia L, Furling D (2011) Selective silencing of mutated mRNAs in DM1 by using modified hU7-snRNAs. Nat Struct Mol Biol 18:85–87
  CAS PubMed Google Scholar
• Freier SM, Lima WF, Sanghvi YS, Vickers T, Zounes M, Cook PD, Ecker DJ (1992) Thermodynamics of antisense oligonucleotide hybridization. In: Izant RPEAJG (ed) Gene regulation: biology of antisense RNA and DNA. Raven, New York, NY, pp 95–107
  Google Scholar
• Fukuyama Y, Osawa M, Suzuki H (1981) Congenital progressive muscular dystrophy of the Fukuyama type—clinical, genetic and pathological considerations. Brain Dev 3:1–29
  CAS PubMed Google Scholar
• Gabanella F, Butchbach ME, Saieva L, Carissimi C, Burghes AH, Pellizzoni L (2007) Ribonucleoprotein assembly defects correlate with spinal muscular atrophy severity and preferentially affect a subset of spliceosomal snRNPs. PLoS One 2:e921
  PubMed Central PubMed Google Scholar
• Gagnon KT, Corey DR (2012) Argonaute and the nuclear RNAs: new pathways for RNA-mediated control of gene expression. Nucleic Acid Ther 22:3–16
  CAS PubMed Central PubMed Google Scholar
• Gagnon KT, Pendergraff HM, Deleavey GF, Swayze EE, Potier P, Randolph J, Roesch EB, Chattopadhyaya J, Damha MJ, Bennett CF et al (2010) Allele-selective inhibition of mutant huntingtin expression with antisense oligonucleotides targeting the expanded CAG repeat. Biochemistry 49:10166–10178
  CAS PubMed Central PubMed Google Scholar
• Gao Z, Cooper TA (2013) Antisense oligonucleotides: rising stars in eliminating RNA toxicity in myotonic dystrophy. Hum Gene Ther 24:499–507
  CAS PubMed Central PubMed Google Scholar
• Gatchel JR, Zoghbi HY (2005) Diseases of unstable repeat expansion: mechanisms and common principles. Nat Rev Genet 6:743–755
  CAS PubMed Google Scholar
• Geary RS (2009) Antisense oligonucleotide pharmacokinetics and metabolism. Expert Opin Drug Metab Toxicol 5:381–391
  CAS PubMed Google Scholar
• Geary RS, Wancewicz E, Matson J, Pearce M, Siwkowski A, Swayze E, Bennett F (2009) Effect of dose and plasma concentration on liver uptake and pharmacologic activity of a 2′-methoxyethyl modified chimeric antisense oligonucleotide targeting PTEN. Biochem Pharmacol 78:284–291
  CAS PubMed Google Scholar
• Geary RS, Yu RZ, Siwkowski A, Levin AA (2007) Pharmacokinetic/pharmacodynamic properties of phosphorothioate 2′-O-(2-methoxyethyl)-modified antisense oligonucleotides in animals and man. In: Crooke ST (ed) Antisense drug technology: principles, strategies, and applications. CRC, Boca Raton, FL, pp 305–326
  Google Scholar
• Geib T, Hertel KJ (2009) Restoration of full-length SMN promoted by adenoviral vectors expressing RNA antisense oligonucleotides embedded in U7 snRNAs. PLoS One 4:e8204
  PubMed Central PubMed Google Scholar
• Ghildiyal M, Zamore PD (2009) Small silencing RNAs: an expanding universe. Nat Rev Genet 10:94–108
  CAS PubMed Central PubMed Google Scholar
• Gilleron J, Querbes W, Zeigerer A, Borodovsky A, Marsico G, Schubert U, Manygoats K, Seifert S, Andree C, Stoter M et al (2013) Image-based analysis of lipid nanoparticle-mediated siRNA delivery, intracellular trafficking and endosomal escape. Nat Biotechnol 31:638–646
  CAS PubMed Google Scholar
• Goemans NM, Tulinius M, van den Akker JT, Burm BE, Ekhart PF, Heuvelmans N, Holling T, Janson AA, Platenburg GJ, Sipkens JA et al (2011) Systemic administration of PRO051 in Duchenne’s muscular dystrophy. N Engl J Med 364:1513–1522
  CAS PubMed Google Scholar
• Gogliotti RG, Hammond SM, Lutz C, Didonato CJ (2010) Molecular and phenotypic reassessment of an infrequently used mouse model for spinal muscular atrophy. Biochem Biophys Res Commun 391:517–522
  CAS PubMed Central PubMed Google Scholar
• Goraczniak R, Behlke MA, Gunderson SI (2009) Gene silencing by synthetic U1 adaptors. Nat Biotechnol 27:257–263
  CAS PubMed Google Scholar
• Guan L, Disney MD (2012) Recent advances in developing small molecules targeting RNA. ACS Chem Biol 7:73–86
  CAS PubMed Google Scholar
• Gunderson SI, Polycarpou-Schwarz M, Mattaj IW (1998) U1 snRNP inhibits pre-mRNA polyadenylation through a direct interaction between U1 70K and poly(A) polymerase. Mol Cell 1:255–264
  CAS PubMed Google Scholar
• Gutschner T, Hammerle M, Eissmann M, Hsu J, Kim Y, Hung G, Revenko A, Arun G, Stentrup M, Gross M et al (2013) The noncoding RNA MALAT1 is a critical regulator of the metastasis phenotype of lung cancer cells. Cancer Res 73:1180–1189
  CAS PubMed Central PubMed Google Scholar
• Guttman M, Rinn JL (2012) Modular regulatory principles of large non-coding RNAs. Nature 482:339–346
  CAS PubMed Google Scholar
• Guttman M, Russell P, Ingolia NT, Weissman JS, Lander ES (2013) Ribosome profiling provides evidence that large noncoding RNAs do not encode proteins. Cell 154:240–251
  CAS PubMed Central PubMed Google Scholar
• Hall JW 3rd (2000) Development of the ear and hearing. J Perinatol 20:S12–S20
  PubMed Google Scholar
• Hamilton G, Gillingwater TH (2013) Spinal muscular atrophy: going beyond the motor neuron. Trends Mol Med 19:40–50
  CAS PubMed Google Scholar
• Han J, Kim D, Morris KV (2007) Promoter-associated RNA is required for RNA-directed transcriptional gene silencing in human cells. Proc Natl Acad Sci U S A 104:12422–12427
  CAS PubMed Central PubMed Google Scholar
• Hanecak R, Brown-Driver V, Fox MC, Azad RF, Furusako S, Nozaki C, Ford C, Sasmor H, Anderson KP (1996) Antisense oligonucleotide inhibition of hepatitis C virus gene expression in transformed hepatocytes. J Virol 70:5203–5212
  CAS PubMed Central PubMed Google Scholar
• Harper PS, Brook JD, Newman E (2001) Myotonic dystrophy. WB Saunders, London, UK
  Google Scholar
• Havens MA, Duelli DM, Hastings ML (2013) Targeting RNA splicing for disease therapy. Wiley Interdiscip Rev RNA 4:247–266
  CAS PubMed Central PubMed Google Scholar
• He Y, Vogelstein B, Velculescu VE, Papadopoulos N, Kinzler KW (2008) The antisense transcriptomes of human cells. Science 322:1855–1857
  CAS PubMed Central PubMed Google Scholar
• Heier CR, Satta R, Lutz C, DiDonato CJ (2010) Arrhythmia and cardiac defects are a feature of spinal muscular atrophy model mice. Hum Mol Genet 19:3906–3918
  CAS PubMed Central PubMed Google Scholar
• Helene C, Toulme JJ (1990) Specific regulation of gene expression by antisense, sense and antigene nucleic acids. Biochim Biophys Acta 1049:99–125
  CAS PubMed Google Scholar
• Henry SP, Giclas PC, Leeds J, Pangburn M, Auletta C, Levin AA, Kornbrust DJ (1997) Activation of the alternative pathway of complement by a phosphorothioate oligonucleotide: potential mechanism of action. J Pharmacol Exp Ther 281:810–816
  CAS PubMed Google Scholar
• Henry SP, Kim T-W, Kramer-Strickland K, Zanardi TA, Fey RA, Levin AA (2007) Toxicologic properties of 2′O-methoxyethyl chimeric antisense inhibitors in animals and man. In: Crooke ST (ed) Antisense drug technology: principles, strategies and applications. CRC, Boca Raton, FL, pp 327–364
  Google Scholar
• Hong DS, Younes A, Fayad L, Fowler NH, Hagemeister FB, Mistry R, Nemunaitis JJ, Borad MJ, Bryce AH, Yamashita M, et al (2013) A phase I study of ISIS 481464 (AZD9150), a first-in-human, first-in-class, antisense oligonucleotide inhibitor of STAT3, in patients with advanced cancers. In American Society of Clinical Oncology Annual Meeting, abstract 8523
  Google Scholar
• Hsieh-Li HM, Chang JG, Jong YJ, Wu MH, Wang NM, Tsai CH, Li H (2000) A mouse model for spinal muscular atrophy. Nat Genet 24:66–70
  CAS PubMed Google Scholar
• Hu J, Liu J, Corey DR (2010) Allele-selective inhibition of huntingtin expression by switching to an miRNA-like RNAi mechanism. Chem Biol 17:1183–1188
  CAS PubMed Central PubMed Google Scholar
• Hu J, Matsui M, Gagnon KT, Schwartz JC, Gabillet S, Arar K, Wu J, Bezprozvanny I, Corey DR (2009) Allele-specific silencing of mutant huntingtin and ataxin-3 genes by targeting expanded CAG repeats in mRNAs. Nat Biotechnol 27:478–484
  CAS PubMed Central PubMed Google Scholar
• Hua Y, Sahashi K, Hung G, Rigo F, Passini MA, Bennett CF, Krainer AR (2010) Antisense correction of SMN2 splicing in the CNS rescues necrosis in a type III SMA mouse model. Genes Dev 24:1634–1644
  CAS PubMed Central PubMed Google Scholar
• Hua Y, Sahashi K, Rigo F, Hung G, Horev G, Bennett CF, Krainer AR (2011) Peripheral SMN restoration is essential for long-term rescue of a severe spinal muscular atrophy mouse model. Nature 478:123–126
  CAS PubMed Central PubMed Google Scholar
• Hua Y, Vickers TA, Baker BF, Bennett CF, Krainer AR (2007) Enhancement of SMN2 exon 7 inclusion by antisense oligonucleotides targeting the exon. PLoS Biol 5:e73
  PubMed Central PubMed Google Scholar
• Hua Y, Vickers TA, Okunola HL, Bennett CF, Krainer AR (2008) Antisense masking of an hnRNP A1/A2 intronic splicing silencer corrects SMN2 splicing in transgenic mice. Am J Hum Genet 82:834–848
  CAS PubMed Central PubMed Google Scholar
• Huntzinger E, Izaurralde E (2011) Gene silencing by microRNAs: contributions of translational repression and mRNA decay. Nat Rev Genet 12:99–110
  CAS PubMed Google Scholar
• Hutvagner G, Zamore PD (2002) A microRNA in a multiple-turnover RNAi enzyme complex. Science 297:2056–2060
  CAS PubMed Google Scholar
• Ivanova G, Reigadas S, Ittig D, Arzumanov A, Andreola ML, Leumann C, Toulme JJ, Gait MJ (2007) Tricyclo-DNA containing oligonucleotides as steric block inhibitors of human immunodeficiency virus type 1 tat-dependent trans-activation and HIV-1 infectivity. Oligonucleotides 17:54–65
  CAS PubMed Google Scholar
• Iversen PL (2007) Morpholinos. In: Crooke ST (ed) Antisense drug technology: principles, strategies, and applications. CRC, Boca Raton, FL, pp 565–582
  Google Scholar
• Jackson AL, Burchard J, Leake D, Reynolds A, Schelter J, Guo J, Johnson JM, Lim L, Karpilow J, Nichols K et al (2006) Position-specific chemical modification of siRNAs reduces “off-target” transcript silencing. RNA 12:1197–1205
  CAS PubMed Central PubMed Google Scholar
• Jackson AL, Linsley PS (2010) Recognizing and avoiding siRNA off-target effects for target identification and therapeutic application. Nat Rev Drug Discov 9:57–67
  CAS PubMed Google Scholar
• Janowski BA, Huffman KE, Schwartz JC, Ram R, Hardy D, Shames DS, Minna JD, Corey DR (2005) Inhibiting gene expression at transcription start sites in chromosomal DNA with antigene RNAs. Nat Chem Biol 1:216–222
  CAS PubMed Google Scholar
• Janowski BA, Younger ST, Hardy DB, Ram R, Huffman KE, Corey DR (2007) Activating gene expression in mammalian cells with promoter-targeted duplex RNAs. Nat Chem Biol 3:166–173
  CAS PubMed Google Scholar
• Janssen HL, Reesink HW, Lawitz EJ, Zeuzem S, Rodriguez-Torres M, Patel K, van der Meer AJ, Patick AK, Chen A, Zhou Y et al (2013) Treatment of HCV infection by targeting microRNA. N Engl J Med 368:1685–1694
  CAS PubMed Google Scholar
• Jayaraman M, Ansell SM, Mui BL, Tam YK, Chen J, Du X, Butler D, Eltepu L, Matsuda S, Narayanannair JK et al (2012) Maximizing the potency of siRNA lipid nanoparticles for hepatic gene silencing in vivo. Angewandte Chemie 51:8529–8533
  CAS PubMed Central PubMed Google Scholar
• Jiang H, Mankodi A, Swanson MS, Moxley RT, Thornton CA (2004) Myotonic dystrophy type 1 is associated with nuclear foci of mutant RNA, sequestration of muscleblind proteins and deregulated alternative splicing in neurons. Hum Mol Genet 13:3079–3088
  CAS PubMed Google Scholar
• Jurica MS, Moore MJ (2003) Pre-mRNA splicing: awash in a sea of proteins. Mol Cell 12:5–14
  CAS PubMed Google Scholar
• Kaida D, Berg MG, Younis I, Kasim M, Singh LN, Wan L, Dreyfuss G (2010) U1 snRNP protects pre-mRNAs from premature cleavage and polyadenylation. Nature 468:664–668
  CAS PubMed Central PubMed Google Scholar
• Kalsotra A, Cooper TA (2011) Functional consequences of developmentally regulated alternative splicing. Nat Rev Genet 12:715–729
  CAS PubMed Central PubMed Google Scholar
• Kanadia RN, Shin J, Yuan Y, Beattie SG, Wheeler TM, Thornton CA, Swanson MS (2006) Reversal of RNA missplicing and myotonia after muscleblind overexpression in a mouse poly(CUG) model for myotonic dystrophy. Proc Natl Acad Sci U S A 103:11748–11753
  CAS PubMed Central PubMed Google Scholar
• Kapeli K, Yeo GW (2012) Genome-wide approaches to dissect the roles of RNA binding proteins in translational control: implications for neurological diseases. Front Neurosci 6:144
  CAS PubMed Central PubMed Google Scholar
• Katayama S, Tomaru Y, Kasukawa T, Waki K, Nakanishi M, Nakamura M, Nishida H, Yap CC, Suzuki M, Kawai J et al (2005) Antisense transcription in the mammalian transcriptome. Science 309:1564–1566
  PubMed Google Scholar
• Kim DH, Saetrom P, Snove O Jr, Rossi JJ (2008) MicroRNA-directed transcriptional gene silencing in mammalian cells. Proc Natl Acad Sci U S A 105:16230–16235
  CAS PubMed Central PubMed Google Scholar
• Kim DH, Villeneuve LM, Morris KV, Rossi JJ (2006) Argonaute-1 directs siRNA-mediated transcriptional gene silencing in human cells. Nat Struct Mol Biol 13:793–797
  CAS PubMed Google Scholar
• Kim HJ, Kim NC, Wang YD, Scarborough EA, Moore J, Diaz Z, MacLea KS, Freibaum B, Li S, Molliex A et al (2013) Mutations in prion-like domains in hnRNPA2B1 and hnRNPA1 cause multisystem proteinopathy and ALS. Nature 495:467–473
  CAS PubMed Central PubMed Google Scholar
• Kinali M, Arechavala-Gomeza V, Feng L, Cirak S, Hunt D, Adkin C, Guglieri M, Ashton E, Abbs S, Nihoyannopoulos P et al (2009) Local restoration of dystrophin expression with the morpholino oligomer AVI-4658 in Duchenne muscular dystrophy: a single-blind, placebo-controlled, dose-escalation, proof-of-concept study. Lancet Neurol 8:918–928
  CAS PubMed Central PubMed Google Scholar
• Kislauskis EH, Zhu X, Singer RH (1994) Sequences responsible for intracellular localization of beta-actin messenger RNA also affect cell phenotype. J Cell Biol 127:441–451
  CAS PubMed Google Scholar
• Kleinman ME, Yamada K, Takeda A, Chandrasekaran V, Nozaki M, Baffi JZ, Albuquerque RJ, Yamasaki S, Itaya M, Pan Y et al (2008) Sequence- and target-independent angiogenesis suppression by siRNA via TLR3. Nature 452:591–597
  CAS PubMed Central PubMed Google Scholar
• Kole R, Krainer AR, Altman S (2012) RNA therapeutics: beyond RNA interference and antisense oligonucleotides. Nat Rev Drug Discov 11:125–140
  CAS PubMed Google Scholar
• Koller E, Vincent TM, Chappell A, De S, Manoharan M, Bennett CF (2011) Mechanisms of single-stranded phosphorothioate modified antisense oligonucleotide accumulation in hepatocytes. Nucleic Acids Res 39:4795–4807
  CAS PubMed Central PubMed Google Scholar
• Koo T, Wood MJ (2013) Clinical trials using antisense oligonucleotides in Duchenne muscular dystrophy. Hum Gene Ther 24:479–488
  CAS PubMed Google Scholar
• Kordasiewicz HB, Stanek LM, Wancewicz EV, Mazur C, McAlonis MM, Pytel KA, Artates JW, Weiss A, Cheng SH, Shihabuddin LS et al (2012) Sustained therapeutic reversal of Huntington’s disease by transient repression of huntingtin synthesis. Neuron 74:1031–1044
  CAS PubMed Central PubMed Google Scholar
• Kornblihtt AR, de la Mata M, Fededa JP, Munoz MJ, Nogues G (2004) Multiple links between transcription and splicing. RNA 10:1489–1498
  CAS PubMed Central PubMed Google Scholar
• Koval ED, Shaner C, Zhang P, du Maine X, Fischer K, Tay J, Chau BN, Wu GF, Miller TM (2013) Method for widespread microRNA-155 inhibition prolongs survival in ALS-model mice. Hum Mol Genet 22(20):4127–4135
  CAS PubMed Google Scholar
• Krawczak M, Reiss J, Cooper DN (1992) The mutational spectrum of single base-pair substitutions in mRNA splice junctions of human genes: causes and consequences. Hum Genet 90:41–54
  CAS PubMed Google Scholar
• Kremer H, van Wijk E, Marker T, Wolfrum U, Roepman R (2006) Usher syndrome: molecular links of pathogenesis, proteins and pathways. Hum Mol Genet 15(Spec No 2):R262–R270
  CAS PubMed Google Scholar
• Krieg AM (2008) Toll-like receptor 9 (TLR9) agonists in the treatment of cancer. Oncogene 27:161–167
  CAS PubMed Google Scholar
• Krol J, Fiszer A, Mykowska A, Sobczak K, de Mezer M, Krzyzosiak WJ (2007) Ribonuclease dicer cleaves triplet repeat hairpins into shorter repeats that silence specific targets. Mol Cell 25:575–586
  CAS PubMed Google Scholar
• Krutzfeldt J, Rajewsky N, Braich R, Rajeev KG, Tuschl T, Manoharan M, Stoffel M (2005) Silencing of microRNAs in vivo with ‘antagomirs’. Nature 438:685–689
  PubMed Google Scholar
• Kuyumcu-Martinez NM, Wang GS, Cooper TA (2007) Increased steady-state levels of CUGBP1 in myotonic dystrophy 1 are due to PKC-mediated hyperphosphorylation. Mol Cell 28:68–78
  CAS PubMed Central PubMed Google Scholar
• Kwoh TJ (2007) An overview of the clinical safety experience of first- and second-generation antisense oligonucleotides. In: Crooke ST (ed) Antisense drug technology: principles, strategies, and applications. CRC, Boca Raton, FL, pp 365–399
  Google Scholar
• Lam MT, Cho H, Lesch HP, Gosselin D, Heinz S, Tanaka-Oishi Y, Benner C, Kaikkonen MU, Kim AS, Kosaka M et al (2013) Rev-Erbs repress macrophage gene expression by inhibiting enhancer-directed transcription. Nature 498:511–515
  CAS PubMed Google Scholar
• Langlois MA, Boniface C, Wang G, Alluin J, Salvaterra PM, Puymirat J, Rossi JJ, Lee NS (2005) Cytoplasmic and nuclear retained DMPK mRNAs are targets for RNA interference in myotonic dystrophy cells. J Biol Chem 280:16949–16954
  CAS PubMed Google Scholar
• Le TT, Pham LT, Butchbach ME, Zhang HL, Monani UR, Coovert DD, Gavrilina TO, Xing L, Bassell GJ, Burghes AH (2005) SMNDelta7, the major product of the centromeric survival motor neuron (SMN2) gene, extends survival in mice with spinal muscular atrophy and associates with full-length SMN. Hum Mol Genet 14:845–857
  CAS PubMed Google Scholar
• Lee JE, Bennett CF, Cooper TA (2012) RNase H-mediated degradation of toxic RNA in myotonic dystrophy type 1. Proc Natl Acad Sci U S A 109:4221–4226
  CAS PubMed Central PubMed Google Scholar
• Lee JT (2012) Epigenetic regulation by long noncoding RNAs. Science 338:1435–1439
  CAS PubMed Google Scholar
• Lee RG, Crosby J, Baker BF, Graham MJ, Crooke RM (2013) Antisense technology: an emerging platform for cardiovascular disease therapeutics. J Cardiovasc Transl Res 6(6):969–980
  PubMed Central PubMed Google Scholar
• Lefave CV, Squatrito M, Vorlova S, Rocco GL, Brennan CW, Holland EC, Pan YX, Cartegni L (2011) Splicing factor hnRNPH drives an oncogenic splicing switch in gliomas. EMBO J 30(19):4084–4097
  CAS PubMed Central PubMed Google Scholar
• Lefebvre S, Burglen L, Reboullet S, Clermont O, Burlet P, Viollet L, Benichou B, Cruaud C, Millasseau P, Zeviani M et al (1995) Identification and characterization of a spinal muscular atrophy-determining gene. Cell 80:155–165
  CAS PubMed Google Scholar
• Lefebvre S, Burlet P, Liu Q, Bertrandy S, Clermont O, Munnich A, Dreyfuss G, Melki J (1997) Correlation between severity and SMN protein level in spinal muscular atrophy. Nat Genet 16:265–269
  CAS PubMed Google Scholar
• Leger AJ, Mosquea LM, Clayton NP, Wu IH, Weeden T, Nelson CA, Phillips L, Roberts E, Piepenhagen PA, Cheng SH et al (2013) Systemic delivery of a peptide-linked morpholino oligonucleotide neutralizes mutant RNA toxicity in a mouse model of myotonic dystrophy. Nucleic Acid Ther 23:109–117
  CAS PubMed Google Scholar
• Lentz J, Pan F, Ng SS, Deininger P, Keats B (2007) Ush1c216A knock-in mouse survives Katrina. Mutat Res 616:139–144
  CAS PubMed Google Scholar
• Lentz J, Savas S, Ng SS, Athas G, Deininger P, Keats B (2005) The USH1C 216G– > A splice-site mutation results in a 35-base-pair deletion. Hum Genet 116:225–227
  CAS PubMed Google Scholar
• Lentz JJ, Gordon WC, Farris HE, MacDonald GH, Cunningham DE, Robbins CA, Tempel BL, Bazan NG, Rubel EW, Oesterle EC et al (2010) Deafness and retinal degeneration in a novel USH1C knock-in mouse model. Dev Neurobiol 70:253–267
  CAS PubMed Central PubMed Google Scholar
• Lentz JJ, Jodelka FM, Hinrich AJ, McCaffrey KE, Farris HE, Spalitta MJ, Bazan NG, Duelli DM, Rigo F, Hastings ML (2013) Rescue of hearing and vestibular function by antisense oligonucleotides in a mouse model of human deafness. Nat Med 19:345–350
  CAS PubMed Central PubMed Google Scholar
• Levin AA, Yu RZ, Geary RS (2007) Basic principles of the pharmacokinetics of antisense oligonucleotide drugs. In: Crooke ST (ed) Antisense drug technology: principles, strategies, and applications. CRC, Boca Raton, FL, pp 183–215
  Google Scholar
• Li LC, Okino ST, Zhao H, Pookot D, Place RF, Urakami S, Enokida H, Dahiya R (2006) Small dsRNAs induce transcriptional activation in human cells. Proc Natl Acad Sci U S A 103:17337–17342
  CAS PubMed Central PubMed Google Scholar
• Liang XH, Vickers TA, Guo S, Crooke ST (2011) Efficient and specific knockdown of small non-coding RNAs in mammalian cells and in mice. Nucleic Acids Res 39:e13
  PubMed Central PubMed Google Scholar
• Licatalosi DD, Darnell RB (2010) RNA processing and its regulation: global insights into biological networks. Nat Rev Genet 11:75–87
  CAS PubMed Central PubMed Google Scholar
• Lightfoot HL, Hall J (2012) Target mRNA inhibition by oligonucleotide drugs in man. Nucleic Acids Res 40:10585–10595
  CAS PubMed Central PubMed Google Scholar
• Lim KH, Ferraris L, Filloux ME, Raphael BJ, Fairbrother WG (2011) Using positional distribution to identify splicing elements and predict pre-mRNA processing defects in human genes. Proc Natl Acad Sci U S A 108:11093–11098
  CAS PubMed Central PubMed Google Scholar
• Lim SR, Hertel KJ (2001) Modulation of survival motor neuron pre-mRNA splicing by inhibition of alternative 3′ splice site pairing. J Biol Chem 276:45476–45483
  CAS PubMed Google Scholar
• Lima W, Wu H, Crooke ST (2007) The RNase H mechanism. In: Crooke ST (ed) Antisense drug technology: principles, strategies, and applications. CRC, Boca Raton, FL, pp 47–74
  Google Scholar
• Lima WF, Monia BP, Ecker DJ, Freier SM (1992) Implication of RNA structure on antisense oligonucleotide hybridization kinetics. Biochemistry 31:12055–12061
  CAS PubMed Google Scholar
• Lima WF, Prakash TP, Murray HM, Kinberger GA, Li W, Chappell AE, Li CS, Murray SF, Gaus H, Seth PP et al (2012) Single-stranded siRNAs activate RNAi in animals. Cell 150:883–894
  CAS PubMed Google Scholar
• Lin F, Worman HJ (1993) Structural organization of the human gene encoding nuclear lamin A and nuclear lamin C. J Biol Chem 268:16321–16326
  CAS PubMed Google Scholar
• Lin X, Miller JW, Mankodi A, Kanadia RN, Yuan Y, Moxley RT, Swanson MS, Thornton CA (2006) Failure of MBNL1-dependent post-natal splicing transitions in myotonic dystrophy. Hum Mol Genet 15:2087–2097
  CAS PubMed Google Scholar
• Liu J, Hu J, Corey DR (2011) Expanding the action of duplex RNAs into the nucleus: redirecting alternative splicing. Nucleic Acids Res 40(3):1240–1250
  PubMed Central PubMed Google Scholar
• Lorenz P, Misteli T, Baker BF, Bennett CF, Spector DL (2000) Nucleocytoplasmic shuttling: a novel in vivo property of antisense phosphorothioate oligodeoxynucleotides. Nucleic Acids Res 28:582–592
  CAS PubMed Central PubMed Google Scholar
• Lorson CL, Androphy EJ (2000) An exonic enhancer is required for inclusion of an essential exon in the SMA-determining gene SMN. Hum Mol Genet 9:259–265
  CAS PubMed Google Scholar
• Lorson CL, Hahnen E, Androphy EJ, Wirth B (1999) A single nucleotide in the SMN gene regulates splicing and is responsible for spinal muscular atrophy. Proc Natl Acad Sci U S A 96:6307–6311
  CAS PubMed Central PubMed Google Scholar
• Lunn MR, Wang CH (2008) Spinal muscular atrophy. Lancet 371:2120–2133
  PubMed Google Scholar
• Mahadevan M, Tsilfidis C, Sabourin L, Shutler G, Amemiya C, Jansen G, Neville C, Narang M, Barcelo J, O’Hoy K et al (1992) Myotonic dystrophy mutation: an unstable CTG repeat in the 3′ untranslated region of the gene. Science 255:1253–1255
  CAS PubMed Google Scholar
• Maniatis T, Reed R (2002) An extensive network of coupling among gene expression machines. Nature 416:499–506
  CAS PubMed Google Scholar
• Mankodi A, Logigian E, Callahan L, McClain C, White R, Henderson D, Krym M, Thornton CA (2000) Myotonic dystrophy in transgenic mice expressing an expanded CUG repeat. Science 289:1769–1773
  CAS PubMed Google Scholar
• Mankodi A, Takahashi MP, Jiang H, Beck CL, Bowers WJ, Moxley RT, Cannon SC, Thornton CA (2002) Expanded CUG repeats trigger aberrant splicing of ClC-1 chloride channel pre-mRNA and hyperexcitability of skeletal muscle in myotonic dystrophy. Mol Cell 10:35–44
  CAS PubMed Google Scholar
• Mankodi A, Urbinati CR, Yuan QP, Moxley RT, Sansone V, Krym M, Henderson D, Schalling M, Swanson MS, Thornton CA (2001) Muscleblind localizes to nuclear foci of aberrant RNA in myotonic dystrophy types 1 and 2. Hum Mol Genet 10:2165–2170
  CAS PubMed Google Scholar
• Mann CJ, Honeyman K, Cheng AJ, Ly T, Lloyd F, Fletcher S, Morgan JE, Partridge TA, Wilton SD (2001) Antisense-induced exon skipping and synthesis of dystrophin in the mdx mouse. Proc Natl Acad Sci U S A 98:42–47
  CAS PubMed Central PubMed Google Scholar
• Manoharan M, Akinc A, Pandey RK, Qin J, Hadwiger P, John M, Mills K, Charisse K, Maier MA, Nechev L et al (2011) Unique gene-silencing and structural properties of 2′-fluoro-modified siRNAs. Angewandte Chemie 50:2284–2288
  CAS PubMed Central PubMed Google Scholar
• Marques JT, Williams BR (2005) Activation of the mammalian immune system by siRNAs. Nat Biotechnol 23:1399–1405
  CAS PubMed Google Scholar
• Martin KC, Ephrussi A (2009) mRNA localization: gene expression in the spatial dimension. Cell 136:719–730
  CAS PubMed Central PubMed Google Scholar
• Mattick JS (2009) The genetic signatures of noncoding RNAs. PLoS Genet 5:e1000459
  PubMed Central PubMed Google Scholar
• Matveeva O, Nechipurenko Y, Rossi L, Moore B, Saetrom P, Ogurtsov AY, Atkins JF, Shabalina SA (2007) Comparison of approaches for rational siRNA design leading to a new efficient and transparent method. Nucleic Acids Res 35:e63
  PubMed Central PubMed Google Scholar
• Matveeva OV, Shabalina SA, Nemtsov VA, Tsodikov AD, Gesteland RF, Atkins JF (2003) Thermodynamic calculations and statistical correlations for oligo-probes design. Nucleic Acids Res 31:4211–4217
  CAS PubMed Central PubMed Google Scholar
• McKay RA, Miraglia LJ, Cummins LL, Owens SR, Sasmor H, Dean NM (1999) Characterization of a potent and specific class of antisense oligonucleotide inhibitor of human protein kinase C-alpha expression. J Biol Chem 274:1715–1722
  CAS PubMed Google Scholar
• McMahon BM, Mays D, Lipsky J, Stewart JA, Fauq A, Richelson E (2002) Pharmacokinetics and tissue distribution of a peptide nucleic acid after intravenous administration. Antisense Nucleic Acid Drug Dev 12:65–70
  CAS PubMed Google Scholar
• McManus CJ, Graveley BR (2011) RNA structure and the mechanisms of alternative splicing. Curr Opin Genet Dev 21:373–379
  CAS PubMed Central PubMed Google Scholar
• McSwiggen J (2013) Specific gene activation by disruption of PRC2-lncRNA interactions. In The Eighteenth Annual Meeting of the RNA Society, abstract 130
  Google Scholar
• Meister G, Landthaler M, Dorsett Y, Tuschl T (2004) Sequence-specific inhibition of microRNA- and siRNA-induced RNA silencing. RNA 10:544–550
  CAS PubMed Central PubMed Google Scholar
• Meister G, Tuschl T (2004) Mechanisms of gene silencing by double-stranded RNA. Nature 431:343–349
  CAS PubMed Google Scholar
• Merideth MA, Gordon LB, Clauss S, Sachdev V, Smith AC, Perry MB, Brewer CC, Zalewski C, Kim HJ, Solomon B et al (2008) Phenotype and course of Hutchinson-Gilford progeria syndrome. N Engl J Med 358:592–604
  CAS PubMed Central PubMed Google Scholar
• Meyer K, Marquis J, Trub J, Nlend Nlend R, Verp S, Ruepp MD, Imboden H, Barde I, Trono D, Schumperli D (2009) Rescue of a severe mouse model for spinal muscular atrophy by U7 snRNA-mediated splicing modulation. Hum Mol Genet 18:546–555
  CAS PubMed Google Scholar
• Meyer KD, Saletore Y, Zumbo P, Elemento O, Mason CE, Jaffrey SR (2012) Comprehensive analysis of mRNA methylation reveals enrichment in 3′ UTRs and near stop codons. Cell 149:1635–1646
  CAS PubMed Central PubMed Google Scholar
• Michele DE, Barresi R, Kanagawa M, Saito F, Cohn RD, Satz JS, Dollar J, Nishino I, Kelley RI, Somer H et al (2002) Post-translational disruption of dystroglycan-ligand interactions in congenital muscular dystrophies. Nature 418:417–422
  CAS PubMed Google Scholar
• Miller JW, Urbinati CR, Teng-Umnuay P, Stenberg MG, Byrne BJ, Thornton CA, Swanson MS (2000) Recruitment of human muscleblind proteins to (CUG)(n) expansions associated with myotonic dystrophy. EMBO J 19:4439–4448
  CAS PubMed Central PubMed Google Scholar
• Ming X, Carver K, Fisher M, Noel R, Cintrat JC, Gillet D, Barbier J, Cao C, Bauman J, Juliano RL (2013) The small molecule Retro-1 enhances the pharmacological actions of antisense and splice switching oligonucleotides. Nucleic Acids Res 41:3673–3687
  CAS PubMed Central PubMed Google Scholar
• Miraglia L, Watt AT, Graham MJ, Crooke ST (2000) Variations in mRNA content have no effect on the potency of antisense oligonucleotides. Antisense Nucleic Acid Drug Dev 10:453–461
  CAS PubMed Google Scholar
• Mitrpant C, Porensky P, Zhou H, Price L, Muntoni F, Fletcher S, Wilton SD, Burghes AH (2013) Improved antisense oligonucleotide design to suppress aberrant SMN2 gene transcript processing: towards a treatment for spinal muscular atrophy. PLoS One 8:e62114
  CAS PubMed Central PubMed Google Scholar
• Miyajima H, Miyaso H, Okumura M, Kurisu J, Imaizumi K (2002) Identification of a cis-acting element for the regulation of SMN exon 7 splicing. J Biol Chem 277:23271–23277
  CAS PubMed Google Scholar
• Mizrahi RA, Schirle NT, Beal PA (2013) Potent and selective inhibition of A-to-I RNA editing with 2′-O-methyl/locked nucleic acid-containing antisense oligoribonucleotides. ACS Chem Biol 8:832–839
  CAS PubMed Central PubMed Google Scholar
• Modarresi F, Faghihi MA, Lopez-Toledano MA, Fatemi RP, Magistri M, Brothers SP, van der Brug MP, Wahlestedt C (2012) Inhibition of natural antisense transcripts in vivo results in gene-specific transcriptional upregulation. Nat Biotechnol 30:453–459
  CAS PubMed Central PubMed Google Scholar
• Monani UR, Lorson CL, Parsons DW, Prior TW, Androphy EJ, Burghes AH, McPherson JD (1999) A single nucleotide difference that alters splicing patterns distinguishes the SMA gene SMN1 from the copy gene SMN2. Hum Mol Genet 8:1177–1183
  CAS PubMed Google Scholar
• Monani UR, Sendtner M, Coovert DD, Parsons DW, Andreassi C, Le TT, Jablonka S, Schrank B, Rossoll W, Prior TW et al (2000) The human centromeric survival motor neuron gene (SMN2) rescues embryonic lethality in Smn(−/−) mice and results in a mouse with spinal muscular atrophy. Hum Mol Genet 9:333–339
  CAS PubMed Google Scholar
• Monia BP, Johnston JF, Ecker DJ, Zounes MA, Lima WF, Freier SM (1992) Selective inhibition of mutant Ha-ras mRNA expression by antisense oligonucleotides. J Biol Chem 267:19954–19962
  CAS PubMed Google Scholar
• Monia BP, Lesnik EA, Gonzalez C, Lima WF, McGee D, Guinosso CJ, Kawasaki AM, Cook PD, Freier SM (1993) Evaluation of 2'-modified oligonucleotides containing 2′-deoxy gaps as antisense inhibitors of gene expression. J Biol Chem 268:14514–14522
  CAS PubMed Google Scholar
• Mordes D, Luo X, Kar A, Kuo D, Xu L, Fushimi K, Yu G, Sternberg P Jr, Wu JY (2006) Pre-mRNA splicing and retinitis pigmentosa. Mol Vis 12:1259–1271
  CAS PubMed Central PubMed Google Scholar
• Morris KV, Chan SW, Jacobsen SE, Looney DJ (2004) Small interfering RNA-induced transcriptional gene silencing in human cells. Science 305:1289–1292
  CAS PubMed Google Scholar
• Morris KV, Santoso S, Turner AM, Pastori C, Hawkins PG (2008) Bidirectional transcription directs both transcriptional gene activation and suppression in human cells. PLoS Genet 4:e1000258
  PubMed Central PubMed Google Scholar
• Morrow JR, Iranzo O (2004) Synthetic metallonucleases for RNA cleavage. Curr Opin Chem Biol 8:192–200
  CAS PubMed Google Scholar
• Moulton HM, Moulton JD (2010) Morpholinos and their peptide conjugates: therapeutic promise and challenge for Duchenne muscular dystrophy. Biochim Biophys Acta 1798:2296–2303
  CAS PubMed Google Scholar
• Moulton JD, Jiang S (2009) Gene knockdowns in adult animals: PPMOs and vivo-morpholinos. Molecules 14:1304–1323
  CAS PubMed Google Scholar
• Mulders SA, van den Broek WJ, Wheeler TM, Croes HJ, van Kuik-Romeijn P, de Kimpe SJ, Furling D, Platenburg GJ, Gourdon G, Thornton CA et al (2009) Triplet-repeat oligonucleotide-mediated reversal of RNA toxicity in myotonic dystrophy. Proc Natl Acad Sci U S A 106:13915–13920
  CAS PubMed Central PubMed Google Scholar
• Muntoni F, Wood MJ (2011) Targeting RNA to treat neuromuscular disease. Nat Rev Drug Discov 10:621–637
  CAS PubMed Google Scholar
• Murray S, Ittig D, Koller E, Berdeja A, Chappell A, Prakash TP, Norrbom M, Swayze EE, Leumann CJ, Seth PP (2012) TricycloDNA-modified oligo-2′-deoxyribonucleotides reduce scavenger receptor B1 mRNA in hepatic and extra-hepatic tissues–a comparative study of oligonucleotide length, design and chemistry. Nucleic Acids Res 40:6135–6143
  CAS PubMed Central PubMed Google Scholar
• Nakamori M, Gourdon G, Thornton CA (2011) Stabilization of expanded (CTG)*(CAG) repeats by antisense oligonucleotides. Mol Ther: J Am Soc Gene Ther 19:2222–2227
  CAS Google Scholar
• Napoli S, Pastori C, Magistri M, Carbone GM, Catapano CV (2009) Promoter-specific transcriptional interference and c-myc gene silencing by siRNAs in human cells. EMBO J 28:1708–1719
  CAS PubMed Central PubMed Google Scholar
• Nilsen TW, Graveley BR (2010) Expansion of the eukaryotic proteome by alternative splicing. Nature 463:457–463
  CAS PubMed Central PubMed Google Scholar
• Obad S, dos Santos CO, Petri A, Heidenblad M, Broom O, Ruse C, Fu C, Lindow M, Stenvang J, Straarup EM et al (2011) Silencing of microRNA families by seed-targeting tiny LNAs. Nat Genet 43:371–378
  CAS PubMed Central PubMed Google Scholar
• Orban TI, Izaurralde E (2005) Decay of mRNAs targeted by RISC requires XRN1, the Ski complex, and the exosome. RNA 11:459–469
  CAS PubMed Central PubMed Google Scholar
• Orengo JP, Chambon P, Metzger D, Mosier DR, Snipes GJ, Cooper TA (2008) Expanded CTG repeats within the DMPK 3′ UTR causes severe skeletal muscle wasting in an inducible mouse model for myotonic dystrophy. Proc Natl Acad Sci U S A 105:2646–2651
  CAS PubMed Central PubMed Google Scholar
• Osborne RJ, Lin X, Welle S, Sobczak K, O’Rourke JR, Swanson MS, Thornton CA (2009) Transcriptional and post-transcriptional impact of toxic RNA in myotonic dystrophy. Hum Mol Genet 18:1471–1481
  CAS PubMed Central PubMed Google Scholar
• Osman EY, Yen PF, Lorson CL (2012) Bifunctional RNAs targeting the intronic splicing silencer N1 increase SMN levels and reduce disease severity in an animal model of spinal muscular atrophy. Mol Ther: J Am Soc Gene Ther 20:119–126
  CAS Google Scholar
• Osorio FG, Navarro CL, Cadinanos J, Lopez-Mejia IC, Quiros PM, Bartoli C, Rivera J, Tazi J, Guzman G, Varela I et al (2011) Splicing-directed therapy in a new mouse model of human accelerated aging. Sci Transl Med 3:106ra107
  PubMed Google Scholar
• Ouyang XM, Yan D, Du LL, Hejtmancik JF, Jacobson SG, Nance WE, Li AR, Angeli S, Kaiser M, Newton V et al (2005) Characterization of Usher syndrome type I gene mutations in an Usher syndrome patient population. Hum Genet 116:292–299
  CAS PubMed Google Scholar
• Overington JP, Al-Lazikani B, Hopkins AL (2006) How many drug targets are there? Nat Rev Drug Discov 5:993–996
  CAS PubMed Google Scholar
• Padgett RA (2012) New connections between splicing and human disease. Trends Genet 28:147–154
  CAS PubMed Central PubMed Google Scholar
• Pallan PS, Greene EM, Jicman PA, Pandey RK, Manoharan M, Rozners E, Egli M (2011) Unexpected origins of the enhanced pairing affinity of 2′-fluoro-modified RNA. Nucleic Acids Res 39:3482–3495
  CAS PubMed Central PubMed Google Scholar
• Passini MA, Bu J, Richards AM, Kinnecom C, Sardi SP, Stanek LM, Hua Y, Rigo F, Matson J, Hung G et al (2011) Antisense oligonucleotides delivered to the mouse CNS ameliorate symptoms of severe spinal muscular atrophy. Sci Transl Med 3:72ra18
  PubMed Central PubMed Google Scholar
• Patel DJ, Ma JB, Yuan YR, Ye K, Pei Y, Kuryavyi V, Malinina L, Meister G, Tuschl T (2006) Structural biology of RNA silencing and its functional implications. Cold Spring Harb Symp Quant Biol 71:81–93
  CAS PubMed Google Scholar
• Peacey E, Rodriguez L, Liu Y, Wolfe MS (2012) Targeting a pre-mRNA structure with bipartite antisense molecules modulates tau alternative splicing. Nucleic Acids Res 40:9836–9849
  CAS PubMed Central PubMed Google Scholar
• Peng CG, Damha MJ (2008) Probing DNA polymerase activity with stereoisomeric 2′-fluoro-β-D-arabinose (2′F-araNTPs) and 2′-fluoro-β-D-ribose (2′F-rNTPs) nucleoside 5′-triphosphates. Can J Chem 86:881–891
  CAS Google Scholar
• Peng Z, Cheng Y, Tan BC, Kang L, Tian Z, Zhu Y, Zhang W, Liang Y, Hu X, Tan X et al (2012) Comprehensive analysis of RNA-Seq data reveals extensive RNA editing in a human transcriptome. Nat Biotechnol 30:253–260
  CAS PubMed Google Scholar
• Perales R, Bentley D (2009) “Cotranscriptionality”: the transcription elongation complex as a nexus for nuclear transactions. Mol Cell 36:178–191
  CAS PubMed Central PubMed Google Scholar
• Petit C (2001) Usher syndrome: from genetics to pathogenesis. Annu Rev Genomics Hum Genet 2:271–297
  CAS PubMed Google Scholar
• Place RF, Li LC, Pookot D, Noonan EJ, Dahiya R (2008) MicroRNA-373 induces expression of genes with complementary promoter sequences. Proc Natl Acad Sci U S A 105:1608–1613
  CAS PubMed Central PubMed Google Scholar
• Polymenidou M, Lagier-Tourenne C, Hutt KR, Bennett CF, Cleveland DW, Yeo GW (2012) Misregulated RNA processing in amyotrophic lateral sclerosis. Brain Res 1462:3–15
  CAS PubMed Central PubMed Google Scholar
• Porensky PN, Mitrpant C, McGovern VL, Bevan AK, Foust KD, Kaspar BK, Wilton SD, Burghes AH (2011) A single administration of morpholino antisense oligomer rescues spinal muscular atrophy in mouse. Hum Mol Genet 21(7):1625–1638
  PubMed Central PubMed Google Scholar
• Prakash TP (2011) An overview of sugar-modified oligonucleotides for antisense therapeutics. Chem Biodivers 8:1616–1641
  CAS PubMed Google Scholar
• Prasanth KV, Prasanth SG, Xuan Z, Hearn S, Freier SM, Bennett CF, Zhang MQ, Spector DL (2005) Regulating gene expression through RNA nuclear retention. Cell 123:249–263
  CAS PubMed Google Scholar
• Preker P, Nielsen J, Schierup MH, Jensen TH (2009) RNA polymerase plays both sides: vivid and bidirectional transcription around and upstream of active promoters. Cell Cycle 8:1106–1107
  CAS PubMed Google Scholar
• Prior TW, Krainer AR, Hua Y, Swoboda KJ, Snyder PC, Bridgeman SJ, Burghes AH, Kissel JT (2009) A positive modifier of spinal muscular atrophy in the SMN2 gene. Am J Hum Genet 85:408–413
  CAS PubMed Central PubMed Google Scholar
• Prior TW, Swoboda KJ, Scott HD, Hejmanowski AQ (2004) Homozygous SMN1 deletions in unaffected family members and modification of the phenotype by SMN2. Am J Med Genet A 130A:307–310
  PubMed Google Scholar
• Proudfoot NJ (2011) Ending the message: poly(A) signals then and now. Genes Dev 25:1770–1782
  CAS PubMed Central PubMed Google Scholar
• Qureshi IA, Mattick JS, Mehler MF (2010) Long non-coding RNAs in nervous system function and disease. Brain Res 1338:20–35
  CAS PubMed Google Scholar
• Rajeev KG, Zimmermann T, Manoharan M, Maier M, Kuchimanchi S, Charisse K (2013) Small interfering RNAs targeting transthyretin mRNA for treatment of transthyretin-associated diseases (Alnylam Pharmaceuticals, USA), WO2013075035A1
  Google Scholar
• Ranum LP, Cooper TA (2006) RNA-mediated neuromuscular disorders. Annu Rev Neurosci 29:259–277
  CAS PubMed Google Scholar
• Ray D, Kazan H, Cook KB, Weirauch MT, Najafabadi HS, Li X, Gueroussov S, Albu M, Zheng H, Yang A et al (2013) A compendium of RNA-binding motifs for decoding gene regulation. Nature 499:172–177
  CAS PubMed Central PubMed Google Scholar
• Renton AE, Majounie E, Waite A, Simon-Sanchez J, Rollinson S, Gibbs JR, Schymick JC, Laaksovirta H, van Swieten JC, Myllykangas L et al (2011) A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. Neuron 72:257–268
  CAS PubMed Central PubMed Google Scholar
• Rettig GR, Behlke MA (2012) Progress toward in vivo use of siRNAs-II. Mol Ther: J Am Soc Gene Ther 20:483–512
  CAS Google Scholar
• Rigo F, Hua Y, Chun SJ, Prakash TP, Krainer AR, Bennett CF (2012a) Synthetic oligonucleotides recruit ILF2/3 to RNA transcripts to modulate splicing. Nat Chem Biol 8:555–561
  CAS PubMed Google Scholar
• Rigo F, Hua Y, Krainer AR, Bennett CF (2012b) Antisense-based therapy for the treatment of spinal muscular atrophy. J Cell Biol 199:21–25
  CAS PubMed Central PubMed Google Scholar
• Riguet E, Tripathi S, Chaubey B, Desire J, Pandey VN, Decout JL (2004) A peptide nucleic acid-neamine conjugate that targets and cleaves HIV-1 TAR RNA inhibits viral replication. J Med Chem 47:4806–4809
  CAS PubMed Google Scholar
• Rinn JL, Chang HY (2012) Genome regulation by long noncoding RNAs. Annu Rev Biochem 81:145–166
  CAS PubMed Google Scholar
• Rochette CF, Gilbert N, Simard LR (2001) SMN gene duplication and the emergence of the SMN2 gene occurred in distinct hominids: SMN2 is unique to Homo sapiens. Hum Genet 108:255–266
  CAS PubMed Google Scholar
• Sahay G, Querbes W, Alabi C, Eltoukhy A, Sarkar S, Zurenko C, Karagiannis E, Love K, Chen D, Zoncu R et al (2013) Efficiency of siRNA delivery by lipid nanoparticles is limited by endocytic recycling. Nat Biotechnol 31:653–658
  CAS PubMed Google Scholar
• Sarma K, Levasseur P, Aristarkhov A, Lee JT (2010) Locked nucleic acids (LNAs) reveal sequence requirements and kinetics of Xist RNA localization to the X chromosome. Proc Natl Acad Sci U S A 107:22196–22201
  CAS PubMed Central PubMed Google Scholar
• Sazani P, Gemignani F, Kang SH, Maier MA, Manoharan M, Persmark M, Bortner D, Kole R (2002) Systemically delivered antisense oligomers upregulate gene expression in mouse tissues. Nat Biotechnol 20:1228–1233
  CAS PubMed Google Scholar
• Sazani P, Graziewicz MA, Kole R (2007) Splice switching oligonucleotides as potential therapeutics. In: Crooke ST (ed) Antisense drug technology: principles, strategies, and applications. CRC, Boca Raton, FL, pp 89–114
  Google Scholar
• Scaffidi P, Misteli T (2005) Reversal of the cellular phenotype in the premature aging disease Hutchinson-Gilford progeria syndrome. Nat Med 11:440–445
  CAS PubMed Central PubMed Google Scholar
• Schoenberg DR, Maquat LE (2012) Regulation of cytoplasmic mRNA decay. Nat Rev Genet 13:246–259
  CAS PubMed Central PubMed Google Scholar
• Schreml J, Riessland M, Paterno M, Garbes L, Rossbach K, Ackermann B, Kramer J, Somers E, Parson SH, Heller R et al (2012) Severe SMA mice show organ impairment that cannot be rescued by therapy with the HDACi JNJ-26481585. Eur J Human Genet 21(6):643–652
  Google Scholar
• Schwartz JC, Younger ST, Nguyen NB, Hardy DB, Monia BP, Corey DR, Janowski BA (2008) Antisense transcripts are targets for activating small RNAs. Nat Struct Mol Biol 15:842–848
  CAS PubMed Central PubMed Google Scholar
• Schweingruber C, Rufener SC, Zund D, Yamashita A, Muhlemann O (2013) Nonsense-mediated mRNA decay—mechanisms of substrate mRNA recognition and degradation in mammalian cells. Biochim Biophys Acta 1829:612–623
  CAS PubMed Google Scholar
• Seila AC, Core LJ, Lis JT, Sharp PA (2009) Divergent transcription: a new feature of active promoters. Cell Cycle 8:2557–2564
  CAS PubMed Google Scholar
• Senn JJ, Burel S, Henry SP (2005) Non-CpG-containing antisense 2′-methoxyethyl oligonucleotides activate a proinflammatory response independent of Toll-like receptor 9 or myeloid differentiation factor 88. J Pharmacol Exp Ther 314:972–979
  CAS PubMed Google Scholar
• Seow Y, Sibley CR, Wood MJ (2012) Artificial mirtron-mediated gene knockdown: functional DMPK silencing in mammalian cells. RNA 18:1328–1337
  CAS PubMed Central PubMed Google Scholar
• Seth PP, Allerson CR, Berdeja A, Siwkowski A, Pallan PS, Gaus H, Prakash TP, Watt AT, Egli M, Swayze EE (2010) An exocyclic methylene group acts as a bioisostere of the 2′-oxygen atom in LNA. J Am Chem Soc 132:14942–14950
  CAS PubMed Central PubMed Google Scholar
• Seth PP, Jazayeri A, Yu J, Allerson CR, Bhat B, Swayze EE (2012a) Structure activity relationships of alpha-L-LNA modified phosphorothioate gapmer antisense oligonucleotides in animals. Mol Ther Nucleic Acids 1:e47
  PubMed Central PubMed Google Scholar
• Seth PP, Siwkowski A, Allerson CR, Vasquez G, Lee S, Prakash TP, Wancewicz EV, Witchell D, Swayze EE (2009) Short antisense oligonucleotides with novel 2′-4′ conformationally restricted nucleoside analogues show improved potency without increased toxicity in animals. J Med Chem 52:10–13
  CAS PubMed Google Scholar
• Seth PP, Yu J, Jazayeri A, Pallan PS, Allerson CR, Ostergaard ME, Liu F, Herdewijn P, Egli M, Swayze EE (2012b) Synthesis and antisense properties of fluoro cyclohexenyl nucleic acid (F-CeNA), a nuclease stable mimic of 2′-fluoro RNA. J Org Chem 77:5074–5085
  CAS PubMed Central PubMed Google Scholar
• Seznec H, Agbulut O, Sergeant N, Savouret C, Ghestem A, Tabti N, Willer JC, Ourth L, Duros C, Brisson E et al (2001) Mice transgenic for the human myotonic dystrophy region with expanded CTG repeats display muscular and brain abnormalities. Hum Mol Genet 10:2717–2726
  CAS PubMed Google Scholar
• Shababi M, Habibi J, Yang HT, Vale SM, Sewell WA, Lorson CL (2010) Cardiac defects contribute to the pathology of spinal muscular atrophy models. Hum Mol Genet 19:4059–4071
  CAS PubMed Google Scholar
• Shababi M, Lorson CL, Rudnik-Schoneborn SS (2013) Spinal muscular atrophy: a motor neuron disorder or a multi-organ disease? J Anat 224(1):15–28
  PubMed Google Scholar
• Shatkin AJ, Manley JL (2000) The ends of the affair: capping and polyadenylation. Nat Struct Biol 7:838–842
  CAS PubMed Google Scholar
• Sheehan JP, Phan TM (2001) Phosphorothioate oligonucleotides inhibit the intrinsic tenase complex by an allosteric mechanism. Biochemistry 40:4980–4989
  CAS PubMed Google Scholar
• Shibahara S, Mukai S, Nishihara T, Inoue H, Ohtsuka E, Morisawa H (1987) Site-directed cleavage of RNA. Nucleic Acids Res 15:4403–4415
  CAS PubMed Central PubMed Google Scholar
• Sierakowska H, Sambade MJ, Agrawal S, Kole R (1996) Repair of thalassemic human beta-globin mRNA in mammalian cells by antisense oligonucleotides. Proc Natl Acad Sci U S A 93:12840–12844
  CAS PubMed Central PubMed Google Scholar
• Singh NK, Singh NN, Androphy EJ, Singh RN (2006) Splicing of a critical exon of human Survival Motor Neuron is regulated by a unique silencer element located in the last intron. Mol Cell Biol 26:1333–1346
  CAS PubMed Central PubMed Google Scholar
• Sipes TB, Freier SM (2008) Prediction of antisense oligonucleotide efficacy using aggregate motifs. J Bioinform Comput Biol 6:919–932
  CAS PubMed Google Scholar
• Siwkowski AM, Malik L, Esau CC, Maier MA, Wancewicz EV, Albertshofer K, Monia BP, Bennett CF, Eldrup AB (2004) Identification and functional validation of PNAs that inhibit murine CD40 expression by redirection of splicing. Nucleic Acids Res 32:2695–2706
  CAS PubMed Central PubMed Google Scholar
• Skordis LA, Dunckley MG, Yue B, Eperon IC, Muntoni F (2003) Bifunctional antisense oligonucleotides provide a trans-acting splicing enhancer that stimulates SMN2 gene expression in patient fibroblasts. Proc Natl Acad Sci U S A 100:4114–4119
  CAS PubMed Central PubMed Google Scholar
• Smith RA, Miller TM, Yamanaka K, Monia BP, Condon TP, Hung G, Lobsiger CS, Ward CM, McAlonis-Downes M, Wei H et al (2006) Antisense oligonucleotide therapy for neurodegenerative disease. J Clin Invest 116:2290–2296
  CAS PubMed Central PubMed Google Scholar
• Sobczak K, Wheeler TM, Wang W, Thornton CA (2013) RNA interference targeting CUG repeats in a mouse model of myotonic dystrophy. Mol Ther: J Am Soc Gene Ther 21:380–387
  CAS Google Scholar
• Spitali P, Aartsma-Rus A (2012) Splice modulating therapies for human disease. Cell 148:1085–1088
  CAS PubMed Google Scholar
• Squires JE, Patel HR, Nousch M, Sibbritt T, Humphreys DT, Parker BJ, Suter CM, Preiss T (2012) Widespread occurrence of 5-methylcytosine in human coding and non-coding RNA. Nucleic Acids Res 40:5023–5033
  CAS PubMed Central PubMed Google Scholar
• Stein CA, Hansen JB, Lai J, Wu S, Voskresenskiy A, Hog A, Worm J, Hedtjarn M, Souleimanian N, Miller P et al (2010) Efficient gene silencing by delivery of locked nucleic acid antisense oligonucleotides, unassisted by transfection reagents. Nucleic Acids Res 38:e3
  CAS PubMed Central PubMed Google Scholar
• Straarup EM, Fisker N, Hedtjarn M, Lindholm MW, Rosenbohm C, Aarup V, Hansen HF, Orum H, Hansen JB, Koch T (2010) Short locked nucleic acid antisense oligonucleotides potently reduce apolipoprotein B mRNA and serum cholesterol in mice and non-human primates. Nucleic Acids Res 38:7100–7111
  CAS PubMed Central PubMed Google Scholar
• Swayze EE, Bhat B (2007) The medicinal chemistry of oligonucleotides. In: Crooke ST (ed) Antisense drug technology: principles, strategies, and applications. CRC, Boca Raton, FL, pp 143–182
  Google Scholar
• Swayze EE, Siwkowski AM, Wancewicz EV, Migawa MT, Wyrzykiewicz TK, Hung G, Monia BP, Bennett CF (2007) Antisense oligonucleotides containing locked nucleic acid improve potency but cause significant hepatotoxicity in animals. Nucleic Acids Res 35:687–700
  CAS PubMed Central PubMed Google Scholar
• Taneja KL, McCurrach M, Schalling M, Housman D, Singer RH (1995) Foci of trinucleotide repeat transcripts in nuclei of myotonic dystrophy cells and tissues. J Cell Biol 128:995–1002
  CAS PubMed Google Scholar
• Taniguchi-Ikeda M, Kobayashi K, Kanagawa M, Yu CC, Mori K, Oda T, Kuga A, Kurahashi H, Akman HO, DiMauro S et al (2011) Pathogenic exon-trapping by SVA retrotransposon and rescue in Fukuyama muscular dystrophy. Nature 478:127–131
  CAS PubMed Central PubMed Google Scholar
• Tazi J, Bakkour N, Stamm S (2009) Alternative splicing and disease. Biochim Biophys Acta 1792:14–26
  CAS PubMed Google Scholar
• Teplova M, Minasov G, Tereshko V, Inamati GB, Cook PD, Manoharan M, Egli M (1999) Crystal structure and improved antisense properties of 2′-O-(2-methoxyethyl)-RNA. Nat Struct Biol 6:535–539
  CAS PubMed Google Scholar
• Toda T, Kobayashi K (1999) Fukuyama-type congenital muscular dystrophy: the first human disease to be caused by an ancient retrotransposal integration. J Mol Med 77:816–823
  CAS PubMed Google Scholar
• Tripathi V, Ellis JD, Shen Z, Song DY, Pan Q, Watt AT, Freier SM, Bennett CF, Sharma A, Bubulya PA et al (2010) The nuclear-retained noncoding RNA MALAT1 regulates alternative splicing by modulating SR splicing factor phosphorylation. Mol Cell 39:925–938
  CAS PubMed Google Scholar
• Turner, A.M., and Morris, K.V. (2010). Controlling transcription with noncoding RNAs in mammalian cells. Biotechniques 48, ix-xvi.
  Google Scholar
• Ulitsky I, Bartel DP (2013) lincRNAs: genomics, evolution, and mechanisms. Cell 154:26–46
  CAS PubMed Central PubMed Google Scholar
• Usman N, Blatt LM (2000) Nuclease-resistant synthetic ribozymes: developing a new class of therapeutics. J Clin Invest 106:1197–1202
  CAS PubMed Central PubMed Google Scholar
• Vaishnaw AK, Gollob J, Gamba-Vitalo C, Hutabarat R, Sah D, Meyers R, de Fougerolles T, Maraganore J (2010) A status report on RNAi therapeutics. Silence 1:14
  PubMed Central PubMed Google Scholar
• Valori CF, Ning K, Wyles M, Mead RJ, Grierson AJ, Shaw PJ, Azzouz M (2010) Systemic delivery of scAAV9 expressing SMN prolongs survival in a model of spinal muscular atrophy. Sci Transl Med 2:35ra42
  PubMed Google Scholar
• van Deutekom JC, Janson AA, Ginjaar IB, Frankhuizen WS, Aartsma-Rus A, Bremmer-Bout M, den Dunnen JT, Koop K, van der Kooi AJ, Goemans NM et al (2007) Local dystrophin restoration with antisense oligonucleotide PRO051. N Engl J Med 357:2677–2686
  PubMed Google Scholar
• Verpy E, Leibovici M, Zwaenepoel I, Liu XZ, Gal A, Salem N, Mansour A, Blanchard S, Kobayashi I, Keats BJ et al (2000) A defect in harmonin, a PDZ domain-containing protein expressed in the inner ear sensory hair cells, underlies Usher syndrome type 1C. Nat Genet 26:51–55
  CAS PubMed Google Scholar
• Vester B, Wengel J (2004) LNA (locked nucleic acid): high-affinity targeting of complementary RNA and DNA. Biochemistry 43:13233–13241
  CAS PubMed Google Scholar
• Vezain M, Saugier-Veber P, Goina E, Touraine R, Manel V, Toutain A, Fehrenbach S, Frebourg T, Pagani F, Tosi M et al (2010) A rare SMN2 variant in a previously unrecognized composite splicing regulatory element induces exon 7 inclusion and reduces the clinical severity of spinal muscular atrophy. Hum Mutat 31:E1110–E1125
  PubMed Google Scholar
• Vickers T, Baker BF, Cook PD, Zounes M, Buckheit RW Jr, Germany J, Ecker DJ (1991) Inhibition of HIV-LTR gene expression by oligonucleotides targeted to the TAR element. Nucleic Acids Res 19:3359–3368
  CAS PubMed Central PubMed Google Scholar
• Vickers TA, Crooke ST (2012) siRNAs targeted to certain polyadenylation sites promote specific, RISC-independent degradation of messenger RNAs. Nucleic Acids Res 40(13):6223–6234
  CAS PubMed Central PubMed Google Scholar
• Vickers TA, Koo S, Bennett CF, Crooke ST, Dean NM, Baker BF (2003) Efficient reduction of target RNAs by small interfering RNA and RNase H-dependent antisense agents. A comparative analysis. J Biol Chem 278:7108–7118
  CAS PubMed Google Scholar
• Vickers TA, Wyatt JR, Burckin T, Bennett CF, Freier SM (2001) Fully modified 2′ MOE oligonucleotides redirect polyadenylation. Nucleic Acids Res 29:1293–1299
  CAS PubMed Central PubMed Google Scholar
• Vickers TA, Wyatt JR, Freier SM (2000) Effects of RNA secondary structure on cellular antisense activity. Nucleic Acids Res 28:1340–1347
  CAS PubMed Central PubMed Google Scholar
• Villemaire J, Dion I, Elela SA, Chabot B (2003) Reprogramming alternative pre-messenger RNA splicing through the use of protein-binding antisense oligonucleotides. J Biol Chem 278: 50031–50039
  CAS PubMed Google Scholar
• Vitiello D, Pecchia DB, Burke JM (2000) Intracellular ribozyme-catalyzed trans-cleavage of RNA monitored by fluorescence resonance energy transfer. RNA 6:628–637
  CAS PubMed Central PubMed Google Scholar
• Vitte JM, Davoult B, Roblot N, Mayer M, Joshi V, Courageot S, Tronche F, Vadrot J, Moreau MH, Kemeny F et al (2004) Deletion of murine Smn exon 7 directed to liver leads to severe defect of liver development associated with iron overload. Am J Pathol 165:1731–1741
  CAS PubMed Central PubMed Google Scholar
• Voigt T, Meyer K, Baum O, Schumperli D (2010) Ultrastructural changes in diaphragm neuromuscular junctions in a severe mouse model for Spinal Muscular Atrophy and their prevention by bifunctional U7 snRNA correcting SMN2 splicing. Neuromuscul Disord 20:744–752
  PubMed Google Scholar
• Vorlova S, Rocco G, Lefave CV, Jodelka FM, Hess K, Hastings ML, Henke E, Cartegni L (2011) Induction of antagonistic soluble decoy receptor tyrosine kinases by intronic polya activation. Mol Cell 43:927–939
  CAS PubMed Central PubMed Google Scholar
• Wahlestedt C (2013) Targeting long non-coding RNA to therapeutically upregulate gene expression. Nat Rev Drug Discov 12:433–446
  CAS PubMed Google Scholar
• Wan L, Battle DJ, Yong J, Gubitz AK, Kolb SJ, Wang J, Dreyfuss G (2005) The survival of motor neurons protein determines the capacity for snRNP assembly: biochemical deficiency in spinal muscular atrophy. Mol Cell Biol 25:5543–5551
  CAS PubMed Central PubMed Google Scholar
• Wan Y, Kertesz M, Spitale RC, Segal E, Chang HY (2011) Understanding the transcriptome through RNA structure. Nat Rev Genet 12:641–655
  CAS PubMed Google Scholar
• Wancewicz EV, Maier MA, Siwkowski AM, Albertshofer K, Winger TM, Berdeja A, Gaus H, Vickers TA, Bennett CF, Monia BP et al (2010) Peptide nucleic acids conjugated to short basic peptides show improved pharmacokinetics and antisense activity in adipose tissue. J Med Chem 53:3919–3926
  CAS PubMed Central PubMed Google Scholar
• Wang GS, Cooper TA (2007) Splicing in disease: disruption of the splicing code and the decoding machinery. Nat Rev Genet 8:749–761
  CAS PubMed Google Scholar
• Ward AJ, Rimer M, Killian JM, Dowling JJ, Cooper TA (2010) CUGBP1 overexpression in mouse skeletal muscle reproduces features of myotonic dystrophy type 1. Hum Mol Genet 19: 3614–3622
  CAS PubMed Central PubMed Google Scholar
• Watanabe TA, Geary RS, Levin AA (2006) Plasma protein binding of an antisense oligonucleotide targeting human ICAM-1 (ISIS 2302). Oligonucleotides 16:169–180
  CAS PubMed Google Scholar
• Weismann D, Erion DM, Ignatova-Todorava I, Nagai Y, Stark R, Hsiao JJ, Flannery C, Birkenfeld AL, May T, Kahn M et al (2011) Knockdown of the gene encoding Drosophila tribbles homologue 3 (Trib3) improves insulin sensitivity through peroxisome proliferator-activated receptor-gamma (PPAR-gamma) activation in a rat model of insulin resistance. Diabetologia 54: 935–944
  CAS PubMed Central PubMed Google Scholar
• Wheeler TM, Leger AJ, Pandey SK, MacLeod AR, Nakamori M, Cheng SH, Wentworth BM, Bennett CF, Thornton CA (2012) Targeting nuclear RNA for in vivo correction of myotonic dystrophy. Nature 488:111–115
  CAS PubMed Google Scholar
• Wheeler TM, Lueck JD, Swanson MS, Dirksen RT, Thornton CA (2007) Correction of ClC-1 splicing eliminates chloride channelopathy and myotonia in mouse models of myotonic dystrophy. J Clin Invest 117:3952–3957
  CAS PubMed Central PubMed Google Scholar
• Wheeler TM, Sobczak K, Lueck JD, Osborne RJ, Lin X, Dirksen RT, Thornton CA (2009) Reversal of RNA dominance by displacement of protein sequestered on triplet repeat RNA. Science 325:336–339
  CAS PubMed Central PubMed Google Scholar
• Williams JH, Schray RC, Patterson CA, Ayitey SO, Tallent MK, Lutz GJ (2009) Oligonucleotide-mediated survival of motor neuron protein expression in CNS improves phenotype in a mouse model of spinal muscular atrophy. J Neurosci 29:7633–7638
  CAS PubMed Google Scholar
• Wilusz JE, Devanney SC, Caputi M (2005) Chimeric peptide nucleic acid compounds modulate splicing of the bcl-x gene in vitro and in vivo. Nucleic Acids Res 33:6547–6554
  CAS PubMed Central PubMed Google Scholar
• Wooddell CI, Rozema DB, Hossbach M, John M, Hamilton HL, Chu Q, Hegge JO, Klein JJ, Wakefield DH, Oropeza CE et al (2013) Hepatocyte-targeted RNAi therapeutics for the treatment of chronic hepatitis B virus infection. Mol Ther: J Am Soc Gene Ther 21:973–985
  CAS Google Scholar
• Woolf TM, Chase JM, Stinchcomb DT (1995) Toward the therapeutic editing of mutated RNA sequences. Proc Natl Acad Sci U S A 92:8298–8302
  CAS PubMed Central PubMed Google Scholar
• Worman HJ, Fong LG, Muchir A, Young SG (2009) Laminopathies and the long strange trip from basic cell biology to therapy. J Clin Invest 119:1825–1836
  CAS PubMed Central PubMed Google Scholar
• Wu H, Lima WF, Zhang H, Fan A, Sun H, Crooke ST (2004) Determination of the role of the human RNase H1 in the pharmacology of DNA-like antisense drugs. J Biol Chem 279:17181–17189
  CAS PubMed Google Scholar
• Xiao J, Yang B, Lin H, Lu Y, Luo X, Wang Z (2007) Novel approaches for gene-specific interference via manipulating actions of microRNAs: examination on the pacemaker channel genes HCN2 and HCN4. J Cell Physiol 212:285–292
  CAS PubMed Google Scholar
• Yelin R, Dahary D, Sorek R, Levanon EY, Goldstein O, Shoshan A, Diber A, Biton S, Tamir Y, Khosravi R et al (2003) Widespread occurrence of antisense transcription in the human genome. Nat Biotechnol 21:379–386
  CAS PubMed Google Scholar
• Yin H, Betts C, Saleh AF, Ivanova GD, Lee H, Seow Y, Kim D, Gait MJ, Wood MJ (2010) Optimization of peptide nucleic acid antisense oligonucleotides for local and systemic dystrophin splice correction in the mdx mouse. Mol Ther: J Am Soc Gene Ther 18:819–827
  CAS Google Scholar
• Yokota T, Lu QL, Partridge T, Kobayashi M, Nakamura A, Takeda S, Hoffman E (2009) Efficacy of systemic morpholino exon-skipping in Duchenne dystrophy dogs. Ann Neurol 65:667–676
  PubMed Google Scholar
• Yong J, Wan L, Dreyfuss G (2004) Why do cells need an assembly machine for RNA-protein complexes? Trends Cell Biol 14:226–232
  CAS PubMed Google Scholar
• Younger ST, Corey DR (2011) Transcriptional gene silencing in mammalian cells by miRNA mimics that target gene promoters. Nucleic Acids Res 39(13):5682–5691
  CAS PubMed Central PubMed Google Scholar
• Yu D, Pendergraff H, Liu J, Kordasiewicz HB, Cleveland DW, Swayze EE, Lima WF, Crooke ST, Prakash TP, Corey DR (2012) Single-stranded RNAs use RNAi to potently and allele-selectively inhibit mutant huntingtin expression. Cell 150:895–908
  CAS PubMed Central PubMed Google Scholar
• Yu RZ, Zhang H, Geary RS, Graham M, Masarjian L, Lemonidis K, Crooke R, Dean NM, Levin AA (2001) Pharmacokinetics and pharmacodynamics of an antisense phosphorothioate oligonucleotide targeting Fas mRNA in mice. J Pharmacol Exp Ther 296:388–395
  CAS PubMed Google Scholar
• Zamecnik PC, Stephenson ML (1978) Inhibition of Rous sarcoma virus replication and cell transformation by a specific oligodeoxynucleotide. Proc Natl Acad Sci U S A 75:280–284
  CAS PubMed Central PubMed Google Scholar
• Zammarchi F, de Stanchina E, Bournazou E, Supakorndej T, Martires K, Riedel E, Corben AD, Bromberg JF, Cartegni L (2011) Antitumorigenic potential of STAT3 alternative splicing modulation. Proc Natl Acad Sci U S A 108(43):17779–17784
  CAS PubMed Central PubMed Google Scholar
• Zhao J, Ohsumi TK, Kung JT, Ogawa Y, Grau DJ, Sarma K, Song JJ, Kingston RE, Borowsky M, Lee JT (2010) Genome-wide identification of polycomb-associated RNAs by RIP-seq. Mol Cell 40:939–953
  CAS PubMed Central PubMed Google Scholar
• Zhou H, Janghra N, Mitrpant C, Dickinson RL, Anthony K, Price L, Eperon IC, Wilton SD, Morgan J, Muntoni F (2013) A novel morpholino oligomer targeting ISS-N1 improves rescue of severe spinal muscular atrophy transgenic mice. Hum Gene Ther 24:331–342
  CAS PubMed Central PubMed Google Scholar